C/O Homology Medicines, Inc., One Patriots Park, Bedford, Massachusetts
Summary
The estimated net worth of Gabriel Cohn is at least $11.5 K dollars as of January 12, 2022. Gabriel Cohn is the Chief Medical Officer of Homology Medicines, Inc. and owns shares of Q32 Bio Inc. (FIXX) stock worth about $11.5 K.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.